 |
|
 |
|
 |
|
 |
|
 |
|
 |
RESEARCH ACTIVITIES
PINACIDIL AND/OR DIURETIC VS. PLACEBO IN MILD TO MODERATE HYPERTENSION.
ELI LILLY & COMPANY.
A MULTI-CENTER, OBSERVER-BLIND COMPARATIVE STUDY OF ORAL RU965 AND ERYTHROMYCIN ETHLYSUCCINATE IN THE TREATMENT OF PATIENTS WITH INFECTIONS CAUSED BY SUSCEPTIBLE PATHOGENS, HOECHST-ROUSSEL PHARMACEUTICAL.
PINDAC-HCTZ COMBINATION: EFFICACY AND SAFETY IN HYPERTENSION.
ELI LILLY & COMPANY.
A DOUBLE-BLIND, PARALLEL, RANDOMIZED, PLACEBO-CONTROLLED COMPARISON OF "SOMA" COMPOUND AND ITS COMPONENTS. WALLACE LABORATORIES.
MULTI-CENTER RANDOMIZED STUDY OF EVALUATE THE SAFETY AND EFFICACY OF LAXACIN VS. AMOXICILLIN IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTION IN ADULTS. ORTHO PHARMACEUTICALS.
EVALUATION OF EFFICACY AND SAFETY OF COMBINATION THERAPY WITH RAMIPRIL PLUS HYDROCHLOROTHIAZIDE VS. MONOTHERAPY WITH EITHER RAMIPRIL OR HYDROCHLOROTHIAZIDE ALONE IN PATIENTS WITH HYPERTENSION. HOECHST-ROUSSEL PHARMACEUTICALS.
EVALUATION OF LABETALOL FOR THE TREATMENT OF ISOLATED SYSTOLIC OR ESSENTIAL HYPERTENSION IN THE ELDERLY. GLAX0.
THE SAFETY AND EFFECTIVENESS OF FOUR DOSES OF BETAXOLOL HCL VS. PLACEBO IN THE HYPERTENSIVE PATIENTS: A MULTI-CENTER, DOUBLE-BLIND, PARALLEL STUDY. LOREX PHARMACEUTICALS.
A MULTI-CENTER RANDOMIZED, DOUBLE-BLIND, PARALLEL COMPARISON OF FOSINOPRIL SODIUM AND ENALAPRIL MALEATE FOR THE TREATMENT OF MILD TO MODERATE ESSENTIAL HYPERTENSION. SQUIBB.
AN OPEN-LABEL STUDY OF MARKETED NSAID TREATMENT IN PATIENTS WITH OSTEOARTHRITIS. CIBA-GEIGY.
AN OPEN-LABEL STUDY OF VOLTAREN TREATMENT IN PATIENT WITH OSTEOARTHRITIS. CIBA-GEIGY.
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO COMPARE THE EFFICACY OF 100mg AND 200mg DIMETIDENE SWALLOW CAPLETS AND ANTACID SWALLOW CAPLETS IN RELIEVING EPISODIC HEARTBURN/ACID INDIGESTION. SMITH KLINE & FRENCH LABORATORIES.
A PILOT STUDY TO DETERMINE THE EFFECTIVENESS OF VARYING DOSES OF HYDROCHLORATHIZIDE WHEN COMBINE WITH DILTIAZEM SR IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION. MARION LABORATORIES, INC.
A RANDOMIZED, DOUBLE-BLIND, DOSE TITRATION, CROSSOVER, COMPARATIVE STUDY OF AMBULATORY BLOOD PRESSURE RESPONSE TO TREATMENT WITH BETAXOLOL VS. ATENOLOL IN HYPERTENSIVE PATIENTS. G.D. SEARLE AND COMPANY.
A RANDOMIZED, DOUBLE-BLIND PARALLEL GROUP, DOSE RESPONSE STUDY COMPARING THE EFFICACY AND SAFETY OF 5mg, 10mg, AND 20mg OF BISOPROLOL TO PLACEBO GIVEN ONCE DAILY IN PATIENTS WITH MILD OT MODERATE HYPERTENSION. AMERICA CYANAMID COMPANY.
LOVASTATIN DOSE RANGING MULTI-CENTER STUDY IN PATIENTS WITH TYPE II HYPERCHOLESTEROLEMIA, TOTAL CHOLESTEROL 240-300mg/DL WITH OR WITHOUT OTHER FACTORS AND WITH OR WITHOUT EVIDENCE OF CORONARY ARTERY DISEASE. MERCK SHARP AND DOME.
A PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL OF NIFEDIPINE GITS AND ATENOLOL OF THE QUALITY OF LIFE IN MILD TO MODERATE HYPERTENSION. PFIZER.
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO COMPARE THE EFFICACY OF 200mg AND 400mg CIMETIDINE SWALLOW CAPLET AND AN ANTACID SWALLOW CAPLET IN RELIEVING EPISODIC HEARTBURN/ACID INDIGESTION. SMITH KLINE BEECHAM COMPANY.
PROTOCOL FOR THE MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ISRADIPINE (PN 200-110), ADMINISTERED TWICE A DAY, COMPARED TO PLACEBO, IN THE TREATMENT OF ESSENTIAL HYPERTENSION. SANDOZ RESEARCH INSTITUTE.
AN OPEN LABEL, OBSERVER BLIND, EFFICACY, SAFETY AND TOLERABILITY STUDY COMPARING METOPROLOL FUMARATE OROS AND DYAZIDE IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE HYPERTENSION. CIBA GEIGY.
DOUBLE BLIND, DOUBLE CROSSOVER, SINGLE DOSE COMPARISON OF CLIDINIUM BROMIDE WITH PLACEBO IN PATIENTS WITH IRRITABLE BOWEL SYNDROME. HOFFMAN LA-ROCHE.
A MULTI-CENTER COMPARISON OF THE SAFETY AND EFFICACY OF LAMEFLOXACIN AND NORFLOXACIN IN THE TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION, G.D. SEARLE AND COMPANY.
ORAL CONTRACEPTION WITH NORGESTIMATE VERSUS LO OVRAL.
COMPARATIVE STUDY OF ABBOTT 56268 AND AMPICILLIN IN THE TREATMENT OF OUTPATIENTS WITH AN ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS. ABBOTT LABORATORIES.
OGEN AND PREMARIN FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE. ABBOTT.
COMPARATIVE SAFETY AND EFFICACY OF CLARITHROMYCIN (TE-031) AND ERYTHROMYCIN IN THE TREATMENT OF COMMUNITY ACQUIRED PNEUMONIA. ABBOTT LABORATORIES.
THE SAFETY AND EFFICACY OF TEMAFLOXACIN 600mg BID COMPARED TO CIPROFLOXACIN 750mg BID IN THE TREATMENT OF BACTERIAL SKIN OR SKIN STRUCTURE INFECTION. ABBOTT LABORATORIES.
AZITHROMYCIN IN THE STREPTOCOCCAL PHARYNGITIS IN OUTPATIENTS. A MULTI-CENTER THIRD PARTY BLINDED TRIAL EMPLOYING PENICILLIN V (V CILLIN K) AS A COMPARATIVE AGENT. PFIZER,
AZITHROMYCIN IN THE TREATMENT OF SKIN AND SKIN STRUCTURE INFECTIONS. A MULTI-CENTER THIRD PARTY BLINDED TRIAL EMPLOYING KEFLEX AS A COMPARATIVE AGENT. PFIZER.
COMPARATIVE DOUBLE BLIND STUDY OF THE SAFETY AND EFFICACY OF ONCE DAILY DOSES OF NIFEDIPIN 30, 60, AND 90mg CORE COAT TABLETS vs. PLACEBO IN HYPERTENSIVE PATIENTS. MILES.
A PHASE III, MULTI-CENTER, DOUBLE-BLIND, PARALLEL GROUP, PROSPECTIVE RANDOMIZED COMPARATIVE STUDY OF CEFPODOXIME PROXETIL AND AMOXICILLIN IN THE TREATMENT OF OUTPATIENTS WITH UNCOMPLICATED URINARY TRACT INFECTIONS. SANKYO.
TRAMADOL HYDROCHLORIDE: SAFETY AND EFFICACY COMPARED TO ACETAMINOPHEN WITH CODEINE PHOSPHATE IN ELDERLY PATIENTS WITH CHRONIC PAIN. McNEIL.
A DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO DEMONSTRATE THE EFFICACY OF SOMA COMPOUND AND THE CONTRIBUTION OF THE INDIVIDUAL INGREDIENTS (CARISOPRODOL: ASPIRIN) TO THE OVERALL EFFECT OF THE COMBINATION IN THE TREATMENT OF THE ACUTE PAINFUL MUSCULOSKELETAL CONDITIONS OF THE LOWER BACK. CARTER WALLACE.
A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF PLACEBO, BISOPROLOL 5mg, BISOPROLOL 5mg AND HCTZ 6.25mg, AND HCTZ 25mg GIVEN ONCE DAILY IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION. AMERICAN CYNAMID.
ORAL CONTRACEPTION 092-002 WITH CTR 99 VERSUS CTR 77 VERSUS ORTHO NOVUM 7/7/7.
THE CONTROL OF PAIN IN THE TREATMENT OF ACUTE ANAL FISSURES, PARKE DAVIS.
A MULTI-CENTER EVALUATION OF ROBAXISAL WITH CODEINE FOR EFFICACY, SAFETY AND CONTRIBUTION OF COMPONENT INGREDIENTS. A.H. ROBBINS COMPANY
A STUDY OF SUCRALFATE vs. PLACEBO IN THE SYMPTOMATIC RELIEF OF RECURRENT UPSET STOMACH. SCHERING-PLOUGH.
A LONG TERM, OPEN-LABEL EXTENSION FOR PATIENTS COMPLETING STUDY S89-046. SCHERING-PLOUGH.
A DOUBLE-BLIND, PLACEBO CONTROLLED COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF NIFEDIPINE SUSTAINED RELEASE (SR) TABLETS TITRATED FROM 20mg TO 100mg DAILY vs. VERAPAMIL SR TABLETS TITRATED FROM 240mg TO 480mg DAILY IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. MILES, INC.
A COMPARATIVE TRIAL OF CEFPROZIL (500mg BID) vs. CEFUROXIME AXETIL (500mg BID) IN THE TREATMENT OF MILD TO MODERATE LOWER RESPIRATORY TRACT INFECTIONS. BRISTOL MYERS.
COMPARATIVE DOUBLE-BLIND TRIAL COMPARING THE EFFICACY OF ONCE DAILY DOSES OF NIFEDIPINE 30. 60, AND 90mg CORE COAT TABLES vs. PLACEBO IN HYPERTENSIVE PATIENTS. MILE.
A PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL COMPARING THE EFFECTS OF CAPTOPRIL AND ENALAPRIL ON QUALITY OF LIFE IN THE OLDER HYPERTENSIVE PATIENTS. SQUIBB U.S. PHARMACEUTICAL.
A DOUBLE-BLIND RANDOMIZED STUDY OF THE SAFETY AND EFFICACY OF ONCE DAILY DOSES OF NISOLDIPINE COAT-CORE TABLETS 30mg, 60mg (2 X 30) vs. PLACEBO IN HYPERTENSIVE PATIENTS. MILES, INC.
A DOSE-RESPONSE STUDY OF TEBUFELONE IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE. PROCTER AND GAMBLE.
DOUBLE-BLIND, PLACEBO-CONTROLLED EVALUATION OF THE EFFICACY AND SAFETY OF 600mg TRENTAL (PENTOXIFYLLINE) TABLETS IN PATIENTS WITH INTERMITTENT CLAUDICATION. HOECHST-ROUSSEL PHARMACEUTICALS, INC.
TRAMADOL HYDROCHLORIDE: SAFETY AND EFFICACY COMPARED TO ACETAMINOPHEN WITH CODEINE PHOSPHATE IN ELDERLY PATIENTS WITH CHRONIC PAIN. McNEIL.
A COMPARISON OF THE SAFETY AND EFFICACY OF LOMEFIOXACIN AND CIPROFIOXACIN IN THE TREATMENT OF NON-NECROTIZING SKIN AND SKIN STRUCTURE INFECTIONS. G.D. SEARLE AND CO.
A MULTI-CENTER COMPARISON OF THE SAFETY AND EFFICACY OF LOMEFIOXACIN AND OFIOXACIN IN THE TREATMENT OF CHRONIC BACTERIAL PROSTATITIS. G.D. SEARLE AND CO.
A MULTI-CENTER COMPARISON OF THE SAFETY AND EFFICACY OF LOMEFIOXACIN AND OFIOXACIN IN THE TREATMENT OF CHRONIC BACTERIAL PROSTATITIS. G.D. SEARLE AND CO.
LORACARBEF vs. DEFTIN IN ACUTE EXACERBATION OF CHRONIC BRONCHITIS. ELI LILLY AND CO.
A DOUBLE-BLIND RANDOMIZED STUDY OF THE SAFETY AND EFFICACY OF ONCE QD DOSES OF NISOLFIPINE COAT CORE TABLETS 30mg, 60mg, (2 X 30mg), AND 90mg (3 X 30mg) vs. PLACEBO IN HYPERTENSIVE PATIENTS. MILES.
A DOUBLE-BLIND PLACEBO CONTROLLED COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF NIFIDIPINE SUSTAINED-RELEASE (SR) TABLETS TITRATED FROM 20mg TO 100mg DAILY vs. VERAPAMIL SR TABLETS TITRATED FROM 240mg TO 480mg DAILY IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. PFIZER.
MULTI-CENTER, PROSPECTIVE, RANDOMIZED, SINGLE-DOSE, DOUBLE-BLIND, PARALLEL DESIGN COMPARISON OF THE ANTIPYRETIC ACTIVITY OF KETOPROFEN 12.5 AND 25mg (2 X 12.5mg) vs. ACETAMINOPHEN 650mg (2 X 325mg) AND PLACEBO IN ADULT PATIENTS WITH PYREXIA DUE TO UPPER RESPIRATORY TRACT INFECTIONS. MILES.
DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF BAY W 9798 IN PATIENT WITH INTERMITTENT CLAUDICATION. MILES.
COMPARISON OF FOSINOPRIL SODIUM AND NIFEDIPINE GITS IN OLDER PATIENT WITH MILD TO MODERATE ESSENTIAL HYPERTENSION WITH THE ADDITION OF LOW-DOSE HYDROCHLOROTHIAZIDE FOR NON-RESPONDERS. BRISTOL MYERS SQUIBB.
A DOUBLE-BLIND DOSE RANGING STUDY OF BAY W 6228 IN DOSES OF 50uG, 200uG AND 300uG ONCE DAILY COMPARED TO PLACEBO AND TO LOVASTATIN 40mg ONCE DAILY IN PATIENTS WITH HYPERCHOLESTEROLEMIA. MILES.
DOUBLE-BLIND, RANDOMIZED, COMPARATIVE, MULTI-CENTER STUDY OF RP 64206 (SPARFLOXACIN) vs. OFLOXACIN IN THE TREATMENT OF ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS. RHONE POULENC RORER.
DOUBLE-BLIND,RANDOMIZED, COMPARATIVE, MULTI-CENTER STUDY OF RP 64206 (SPARFLOXACIN) vs. CIPROFLOXIN IN THE TREATMENT OF COMMUNITY ACQUIRED, COMPLICATED/SEVERE UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS. RHONE POULENC RORER.
H2B-341 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI CENTER OF ORAL GR122311X COMPARED WITH RANITIDINE AND GR88502X FOR THE PROPHYLAXIS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG ASSOCIATED GASTRIC OR DUODENAL ULCERS IN PATIENTS WITH OSTEO OR RHEUMATOID ARTHRITIS AND WITHOUT A HISTORY OF GASTRIC OR DUODENAL ULCERS. GLAXO.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP DOSE RESPONSE STUDY OF TEMOCAPRIL HCI (CS-622) IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: 0, 10, 20, 40, AND 80mg DOSES. SANKYO.
OPEN-LABEL, LONG-TERM SAFETY OF RO40-5967 IN THE TREATMENT OF ESSENTIAL HYPERTENSION. HOFFMAN LA-ROCHE, INC.
A MULTI-CENTER, CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF REPEATED ORAL DOSES OF VICOPROFEN (HYDROCODIENE BITARTRATE WITH IBUPROFEN) FOR THE TREATMENT OF CHRONIC PAIN. KNOLL PHARMACEUTICALS.
A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-FINDING STUDY OF THE SAFETY AND EFFICACY OF THREE DOSAGE REGIMENS OF FLEXERIL IN OUTPATIENTS WITH ACUTE SKELETAL MUSCLE SPASM. MERCK RESEARCH LABORATORIES.
A DOUBLE-BLIND, FIXED-DOSE, MULTI-CENTER STUDY COMPARING DN-2327 (4 AND 8mg/DAY) TO BUSPIRONE (25mg/DAY) AND PLACEBO IN PATIENTS WITH GENERALIZED ANXIETY DISORDER. TAP.
A DOUBLE-BLIND, DOSE-RANGING STUDY OF BAY w 6228 IN DOSES OF 50uG, 100uG, AND 200uG ONCE DAILY COMPARED TO PLACEBO AND TO LOVASTATIN 40mg ONCE DAILY IN PATIENTS WITH HYPERCHOLESTEROLEMIA. MILES PHARMACEUTICAL DIVISION.
CLINICAL PHASE III: DILTIAZEM ER/ENALAPRIL COMBINATION THERAPY IN HYPERTENSIVE PATIENTS NOT RESPONDING ADEQUATELY TO DILTIAZEM CD (CARDIZEM CD) MONOTHERAPY, EDPROO1, MARION MERRILL DOW, INC.
CALCIUM ANTAGONIST OPEN LABEL, LONG TERM SAFETY OF RO40-5967 IN THE TREATMENT OF ESSENTIAL HYPERTENSION. ROCHE.
CALCIUM ANTAGONIST OPEN-LABEL, LONG ERM SAFETY OF RO40-5967 IN THE TREATMENT OF CHRONIC STABLE ANGINA. ROCHE.
A RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER, PARALLEL STUDY TO COMPARE THE DURATION OF THE ANTIHYPERTENSIVE EFFECT AND SAFETY OF FOUR DOSE LEVELS OF TAK-536 WITH THAT OF PLACEBO IN PATIENTS WITH MODERATE UNCOMPLICATED ESSENTIAL HYPERTENSION. G.H. BESSELAAR ASSOCIATES.
A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED COMPARISON OF TWO TREATMENT REGIMENS: COZAAR AND HYZAAR vs VASOTEC AND VASOTEC PLUS 25mg HYDROCHLOROTHIAZIDE (EQUIVALENT TO THE COMBINATION DRUG VASERETIC 10/25mg) IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE HYPERTENSION MK 954-CO2335. MERCK & CO.
A DOUBLE-BLIND, TWELVE WEEK STUDY TO COMPARE THE SAFETY AND TOLERABILITY OF THE (S+) ENAMTIOMER OF IBUPROFEN AND RACEMIC IBUPROFEN IN THE TREATMENT OF PAIN DUE TO OSTEOARTHRITIS, CHG 94-1. STERLING HEALTH DIVISION OF STERLING WINTHROP, INC.
A MULTI-CENTER, PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED PARALLEL STUDY TO COMPARE THE EFFICACY AND TOLERABILITY OF 10mg, 20mg, AND 40mg DOSES OF LOVATATIN vs 20mg AND 40mg OF FLUVASTATIN IN THE TREATMENT OF PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, 073. MERCK.
A PHASE II, DOUBLE-BLIND, PLACEBO CONTROLLED, DOSE-RANGE AND SHORT TERM EFFICACY STUDY OF UP269-6 IN HYPERTENSIVE PATIENTS, GHBA-811. G.H. BESSELAAR ASSOCIATES.
A DOUBLE-BLIND AMBULATORY BLOOD PRESSURE MONITORING STUDY OF TEMOCAPRIL HCL (CS-622) IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION, 622-314. SANKYO.
LABEL COMPREHENSION AND ACTUAL USE STUDY OF ZANTAC 75mg AMONG OTC CONSUMERS , ROC-302. GLAXO, INC.
LONG-TERM SURVEILLANCE STUDY OF ZILEUTON PLUS USUAL CARE vs USUAL CARE IN PATIENTS WITH ASTHMA, M94-199. ABBOTT LABORATORIES.
CATAPRES-ITS vs AMLODIPINE IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE HYPERTENSION, 1068A. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
A MULTI-CENTER, DOUBLE-BLIND PLACEBO CONTROLLED, REPLICATIVE PIVOTAL SAFETY AND EFFICACY STUDY OF TWO DOSAGE REGIMENS OF FLEXERIL (5mg AND 2.5mg) IN OUTPATIENTS WITH ACUTE SKELETAL MUSCULAR SPASM, GHBA-927. MERCK RESEARCH LABORATORIES.
A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING THREE DAYS AND SEVEN DAYS OF ORAL THERAPY WITH CP-99,219 (100mg DAILY) AND THREE DAYS THERAPY WITH NORPLOXACIN (400mg BID) FOR THE TREATMENT OF UNCOMPLICATED ACUTE URINARY TRACT INFECTION. PFIZER, 1NC.
A MULTI-CENTER TRIAL OF THE ANTIHYPERTENSIVE ACTIVITY AND SAFETY OF IRBESARTAN IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. BRISTOL MYERS SQUIBB COMPANY.
A RANDOMIZED, DOUBLE-BLIND, PARALLEL TRIAL COMPARING LOTREL 5/10 mg ONCE DAILY, LOTREL 5/20 Mg ONCE DAILY, AMLODIPINE 5 Mg ONCE DAILY, AND AMLODIPINE 10 Mg ONCE DAILY IN PATIENTS AGE 18 - 80 YEARS WITH ESSENTIAL HYPERTENSION INADEQUATELY CONTROLLED WITH AMLOKIPINE 5 Mg ONCE DAILY FOLLOWED BY A SINGLE-BLIND EXTENSION OF LOTREL 5/20 Mg ONCE DAILY. CIBA-GEIGY.
OPEN EVALUATION OF THE SAFETY AND EFFICACY OF MAINTENANCE THERAPY WITH ORAL ANA-756 IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION (PR 820-307-US). WYETH-AYERST RESEARCH.
A RANDOMIZED, DOUBLE-BLIND MULTI-CENTER PILOT TRIAL OF ONCE DAILY ECADOTRIL (400mg, 600mg, AND 800mg) vs PLACEBO IN ESSENTIAL HYPERTENSION. BAYER
A MULTI-CENTER, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFECT OF OMEPRAZOLE TRIPLE THERAPY REGIMENS TO DUAL THERAPY REGIMENS ON HELICOBATER PYLORI ERADICATION IN PATIENTS WITH HELICOBACTER PYLORI INFECTION. ASTRA-MERCK.
ONE-YEAR COMPARISON OF REPAGLINIDE AND GLYBURIDE FOR THE TREATMENT OF TYPE II DIABETES.
A RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER PROGESTIN EFFICACY STUDY OF THREE DOSES OF RPR ESTRADIOL/NORETHISTERONE ACETATE (NETA) PATCHES IN A CONTINUOUS WEAR HRT REGIMEN COMPARED TO AN ESTRADIOL 50mg PATCH. RHONE-POULENC RORER PHARMACEUTICALS, INC.
"ESTRADIOL THROUGH THE AGES": A PLACEBO CONTROLLED, RANDOMIZED, AGE-STRATIFIED MULTI-CENTER STUDY OF THE SAFETY, TOLERABILITY AND EFFECTIVENESS OF ESTRACE IN THE TREATMENT OF OSTEOPOROSIS IN POST MENOPAUSAL WOMEN 55 YEARS OF AGE OR OLDER. CORNING PACT.
A DOUBLE-BLIND COMPARISON OF TWO DOSES OF NABUMETONE COMPARED WITH PLACEBO ADMINISTERED ONCE DAILY IN THE MORNING IN THE TREATMENT OF ACUTE ONSET PARASPINAL PAIN (PR-217). SMITHKLINE BEECHAM PHARMACEUTICALS.
A DOUBLE-BLIND COMPARISON OF TWO DOSES OF NABUMETONE COMPARED WITH PLACEBO ADMINISTERED ONCE DAILY IN THE MORNING IN THE TREATMENT OF ACUTE ONSET LARGE MUSCLE BUNDLE PAIN (PR-215). SMITHKLINE BEECHAM PHARMACEUTICALS.
LONG TERM TRIAL OF THE EFFICACY AND SAFETY OF TELMISARTAN (BIBR-277 SE) COMPARED WITH LISINOPRIL IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. BOEHRINGER INGELHEIM.
A DOUBLE-BLIND, RANDOMIZED, VEHICLE-CONTROLLED, PARALLEL GROUP DOSE-RANGING MULTI-CENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF CIVAMIDE CREAM 0.15%, 0.3%, AND 0.6% IN SUBJECTS WITH OSTEOARTHRITIS OF THE KNEE. GENDERM CORPORATION.
A BLINDED, RANDOMIZED PARALLEL GROUP SAFETY AND EFFICACY EVALUATION OF PHZ-136 COMPARED TO COMMERCIALLY AVAILABLE IBUPROFEN IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE. ZAMBON LABORATORIES.
RELIEF OF EPISODIC HEARTBURN: SAFETY AND EFFICACY OF NIZATIDINE 75mg. A PLACEBO CONTROLLED STUDY. WHITEHALL-ROBINS.
A COMPARATOR STUDY OF THE ANALGESIC EFFECT OF LY303870 DIHYDROCHLORIDE TRIHYDRATE IN PATIENTS WITH OSTEOARTHRITIS PAIN. LILLY RESEARCH LABORATORIES.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 4 X 5 FACTORIAL TRIAL OF TELMISARTAN AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH MILD TO-MODERATE ESSENTIAL HYPERTENSION. BOEHRINGER INGELHEIM.
A COMPARISON OF EFFICACY AND SAFETY OF MIBEFRADIL AND NIFEDIPINE GITS OR ENALAPRIL FOR THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION. HOFFMAN LA-ROCHE.
TRANDOLAPRIL IN HYPERTENSION: EFFECTIVENESS WHEN ADDED TO VERAPAMIL SR. KNOLL PHARMACEUTICAL COMPANY.
EVALUATION OF THE EFFICACY AND SAFETY OF CANDESARTAN CILEXETIL IN THE TREATMENT OF PATIENTS WITH HYPERTENSION: A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RESPONSE STUDY. ASTRA MERCK.
EFFICACY AND TOLERABILITY OF FELODIPINE ER IN THE TREATMENT OF STAGE I (JNC V) SYSTOLIC HYPERTENSION IN OLDER PATIENTS OVER A ONE YEAR PERIOD. ASTRA MERCK.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGING STUDY OF CS-866 USING AMBULATORY BLOOD PRESSURE MONITORY IN HYPERTENSIVE PATIENTS. SANKYO USA, CORPORATION.
AN OPEN-LABEL EVALUATION OF THE SAFETY OF CHRONIC ADMINISTRATION OF TELMISARTAN AS MONOTHERAPY OR IN COMBINATION WITH OTHER ANTIHYPERTENSIVE MEDICATIONS. BOEHRINGER INGELHEIM.
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TIMED MEDICATIONS IN THE TREATMENT OF OBESE TYPE II DIABETICS.
MULTI -CENTER, DOUBLE BLIND STUDY TO COMPARE THE SAFETY AND EFFICACY OF LOVASTATIN AND PROBUCOL IN PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM). MERCK SHARP AND DOME.
AN OPEN-LABELED RANDOMIZED PARALLEL GROUP COMPARATIVE MULTI CENTER SAFETY AND EFFICACY STUDY OF TRIPHASIC COMBINATION OF ORAL CONTRACEPTIVES VERSUS ORTHO NOVUM 7/7/7.
COMPARISON OF CEFPAIOXIME PROXETIL (U-76, 252) AND CEFACLOR (CECLOR) IN THE TREATMENT OF ACUTE COMMUNITY ACQUIRED PNEUMONIA. UPJOHN.
THE SAFETY AND EFFICACY OF DILTIAZEM QD vs. PLACEBO IN THE TREATMENT OF ESSENTIAL HYPERTENSION. PROTOCOL DZPRO100 MARION MERRELL DOW.
DIRITHROMYCIN vs. ERYTHROMYCIN BASE IN PNEUMONIA, BRONCHITIS, PHARYNGITIS, AND SKIN INFECTIONS. ELI LILLY.
A MULTI-CENTER, ACTIVE CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL L-OFIOXACIN vs. CEFACLOR IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS IN ADULTS. R.W. JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE.
TWELVE WEEK, DOUBLE-BLIND STUDY OF TROGLITAZONE vs PLACEBO IN NIDDM PATIENTS REQUIRING INSULIN.
(MICONAZOLE NITRATE 2%) VAGINAL CREAM IN THE TREATMENT OF PATIENTS WITH VULVOVAGINAL CANDIDIASIS. BRISTOL MEYERS SQUIBB.
A RANDOMIZED, DOUBLE- BLIND PLACEBO CONTROLLED, FACTORIAL-DESIGN TRIAL OF ANA-756 ALONE AND IN COMBINATION WITH HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL HYPERTENSION. WYETH-AYERST RESEARCH.
A SIX-MONTH RANDOMIZED, SINGLE DAILY DOSE, DOUBLE-BLIND PARALLEL GROUP MULTI-CENTER STUDY TO COMPARE PIROZICAM-BETA-CYCLODEXTRIN AND FELDENE FOR SAFETY, TOLERABILITY AND SYMPTOMATIC RELIEF IN PATIENTS WITH OSTEOARTHRITIS. CHIESI FARMACEUTICI S.P.A.
DOSE-RESPONSE STUDY OF THE ANALGESIC EFFECT OF LY297802 TARTRATE IN PATIENTS WITH OSTEOARTHRITIS PAIN (PR H3Q-MC-CCCD-117). ELI-LILLY AND COMPANY.
A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED PARALLEL MULTI CENTER STUDY OF MOEXIPRIL IN POSTMENOPAUSAL HYPERTENSIVE WOMEN WHO ARE USING HORMONE REPLACEMENT THERAPY.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, EVALUATION OF A ZANTAC 75/CALCIUM CARBONATE COMBINATION TABLET COMPARED TO ZANTAC 75 ALONE AND CALCIUM CARBONATE ALONE FOR THE TREATMENT OF EPISODIC HEARTBURN. GLAXOWELLCOME
THE SAFETY AND EFFICACY OF DILTIAZEM QD vs. PLACEBO IN THE TREATMENT OF ESSENTIAL HYPERTENSION. PROTOCOL DZPRO100 MARION MERRELL DOW.
DIRITHROMYCIN vs. ERYTHROMYCIN BASE IN PNEUMONIA, BRONCHITIS, PHARYNGITIS, AND SKIN INFECTIONS. ELI LILLY.
A MULTI-CENTER, ACTIVE CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL L-OFIOXACIN vs. CEFACLOR IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS IN ADULTS. R.W. JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE.
TWELVE WEEK, DOUBLE-BLIND STUDY OF TROGLITAZONE vs PLACEBO IN NIDDM PATIENTS REQUIRING INSULIN.
(MICONAZOLE NITRATE 2%) VAGINAL CREAM IN THE TREATMENT OF PATIENTS WITH VULVOVAGINAL CANDIDIASIS. BRISTOL MEYERS SQUIBB.
A RANDOMIZED, DOUBLE- BLIND PLACEBO CONTROLLED, FACTORIAL-DESIGN TRIAL OF ANA-756 ALONE AND IN COMBINATION WITH HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL HYPERTENSION. WYETH-AYERST RESEARCH.
A SIX-MONTH RANDOMIZED, SINGLE DAILY DOSE, DOUBLE-BLIND PARALLEL GROUP MULTI-CENTER STUDY TO COMPARE PIROZICAM-BETA-CYCLODEXTRIN AND FELDENE FOR SAFETY, TOLERABILITY AND SYMPTOMATIC RELIEF IN PATIENTS WITH OSTEOARTHRITIS. CHIESI FARMACEUTICI S.P.A.
DOSE-RESPONSE STUDY OF THE ANALGESIC EFFECT OF LY297802 TARTRATE IN PATIENTS WITH OSTEOARTHRITIS PAIN (PR H3Q-MC-CCCD-117). ELI-LILLY AND COMPANY.
A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED PARALLEL MULTI CENTER STUDY OF MOEXIPRIL IN POSTMENOPAUSAL HYPERTENSIVE WOMEN WHO ARE USING HORMONE REPLACEMENT THERAPY.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, EVALUATION OF A ZANTAC 75/CALCIUM CARBONATE COMBINATION TABLET COMPARED TO ZANTAC 75 ALONE AND CALCIUM CARBONATE ALONE FOR THE TREATMENT OF EPISODIC HEARTBURN. GLAXOWELLCOME
TRAMADOL WITH ACETAMINOPHEN IN LOW BACK PAIN OF NON-MALIGNANT ORIGIN. R.W. JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE.
TRAMADOL WITH ACETAMINOPHEN IN THE PAIN OF OSTEOARTHRITIS OF THE HIP OR KNEE. R,W, JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE.
AN INVESTIGATOR BLINDED MULTI-CENTER TRIAL COMPARING THE EFFICACY AND SAFETY OF VAGISTAT - 1 (TIOCONZAOLE 6.5%) VAGINAL OINTMENT AND MONISTAT - 7.
PROTOCOL FOR A MULTICENTRE, LONG TERM STUDY TO MAXIMIXE MIGRAINE RELIEF WITH 311C90 (MAXIM). ZENECA .
A RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE DOSE OF ALNIDITAN (0.4, 0.8 OR 1.4mg) GIVEN SUBUTANEOUSLY IN THE ACUTE TREATMENT OF MIGRAINE. JANSSEN PHARMACEUTICA.
A RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND, 12 MONTH, DOSE-RANGING, MULTI-CENTER STUDY PROTOCOL TO DETERMINE THE LOWEST EFFECTIVE CONTINUOUS AND SEQUENTIAL TRANSDERMAL NETA DOSE REQUIRED TO PREVENT ESTROGEN-INDUCED ENDOMETRIAL HYPERPLASIA. PROCTER AND GAMBLE.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24 MONTH, DOSE RANGING, MULTI-CENTER STUDY PROTOCOL COMPARING EMTDS TO PLACEBO IN THE PREVENTION OF BONE LOSS IN HYSTERECTOMIZED POSTMENOPAUSAL WOMEN. PROCTER AND GAMBLE.
A MULTI-CENTER, PROSPECTIVE, RANDOMIZED, SINGLE-BLIND, PARALLEL GROUP COMPARISON OF THE SAFETY AND EFFICACY OF THE CLOTRIMAZOLE 1 DAY REGIMENT (500MG VAGINAL INSERT) WITH THE CLOTRIMAZOLE 7-DAY REGIMEN(100MG VAGINAL INSERT) IN THE TREATMENT OF VULVOVAGINAL CADIDIASIS. BAYER CORPORATION.
A DOUBLE-BLIND, RANDOMIZED, ACTIVE CONTROLLED, PARALLEL STUDY COMPARING ETHICAL ESTRADIOL TO 7-DAY PATCH 40, 60, AND 80 ug/DAY TO ORAL PREMARIN 0.625mg/DAY IN THE TREATMENT OF VASOMOTOR SYMPTOMS IN POSTMENOPAUSAL WOMEN. ETHICAL PHARMACEUTICALS LIMITED.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP ASSESSMENT OF THE MAGNITUDE AND DURATION OF THE ANTIHYPERTENSIVE EFFECT OF TELMISARTAN ADMINISTERED ONCE-DAILY: EITHER 1 HOUR BEFORE BREAKFAST OR WITH BREAKFAST. BOEHRINGER INGELHEIM. 1997
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL OF THE ANTIHYPERTENSIVE EFFICACY AND SAFETY OF IRBESARTAN COMPARED WITH LOSARTAN FOR THE TREATMENT OF MILD-TO-MODERATE HIGH BLOOD PRESSURE. BRISTOL-MYERS SQUIBB COMPANY.
A RANDOMIZED DOUBLE-BLIND MULTI-CENTER PROGESTIN EFFICACY STUDY OF THREE DOSES OF ESTRADIOL/NORETHISTERONE ACETATE (NETA) PATCHES IN A SEQUENTIAL WEAR HRT REGIME COMPARED TO AN ESTRADIOL 50 PATCH.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND TRIAL OF THE ANTIHYPERTENSIVE EFFICACY AND SAFETY OF IRBESARTAN IN ELDERLY SUBJECTS WITH MILD-TO-MODERATE HYPERTENSION. BRISTOL-MYERS SQUIBB COMPANY.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SIX MONTH SAFETY AND EFFICACY TRIAL OF 7.5, 15, 30, 45mg QD OF PIOGLITAZONE IN TYPE II DIABETES MELLITUS PATIENTS (NON-INSULIN DEPENDENT DIABETES MELLITUS, (NIDDM). CORNING BESSELAAR.
A MULTICENTER, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE TOLERABILITY OF TEN DAY OMEPRAZOLE TRIPLE THERAPY TO FOURTEEN DAY STANDARD TRIPLE THERAPY IN SUBJECTS RECEIVING TREATMENT FOR HELICOBACTER PYLORI ERADICATION. ASTRA-MERCK.
A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFECTS OF CI-991 ON NONINSULIN DEPENDENT DIABETES MELLITUS (NIDDM) PATIENTS REQUIRING INSULIN. PARKE-DAVIS MEDICAL RESEARCH.
A 26-WEEK RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO CONTROLLED, COMPARISON STUDY TO EVALUATE THE SAFETY, EFFICACY, AND TOLERABILITY OF BRL-49653C THERAPY WHEN ADMINISTERED TO PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM). SMITHKLINE BEECHAM PHARMACEUTICALS.
OPEN EVALUATION OF THE LONG-TERM EFFICACY, SAFETY AND TOLERABILITY OF 1.4mg SC ALNIDITAN IN THE ACUTE TREATMENT OF MIGRAINE ATTACKS. JANSSEN PHARMACEUTICA.
A MULTICENTER, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 25mg, 100mg, AND 400mg SC-58635 BID VERSUS PLACEBO IN TREATING THE SIGN AND SYMPTOMS OF OSTEOARTHRITIS OF THE KNEE.. G. D. SEARLE AND COMPANY.
A LONG TERM, MULTICENTER STUDY TO EVALUATE THE TOLERABILITY OF PRAMLINTIDE (AC 137) IN PATIENTS WITH TYPE I DIABETES MELLITUS. AMYLIN.
A DOUBLE-BLIND, PLACEBO CONTROLLED, RANDOMIZED COMPARISON STUDY OF THE EFFICACY AND SAFETY OF SC-58635 50mg, 100mg, AND 200mg BID AND NAPROXEN 500mg BID IN TREATING THE SIGN AND SYMPTOMS OF OSTEOARTHRITIS OF THE HIP.
G. D. SEARLE AND COMPANY.
A COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF CLARITHROMYCIN EXTENDED RELEASE TABLETS AND LARACARBEF PULVULES FOR THE TREATMENT OF PATIENTS WITH SECONDARY BACTERIAL INFECTIONS OF ACUTE BRONCHITIS. ABBOTT LABORATORIES.
A STUDY OF COMPARED LANSOPRAZOLE TO RANITIDINE IN PATIENTS WITH HEARTBURN. TAP HOLDINGS INC.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO AND ACTIVE CONTROLLED, PARALLEL 8 WEEK DOSE-RANGING STUDY OF THE DUAL METALLOPROTEASE INHIBITOR, BMS-186716, IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. BRISTOL-MYERS SQUIBB CO.
OPEN-LABEL, LONG-TERM STUDY OF THE ANTIHYPERTENSIVE ACTIVITY AND SAFETY OF BMS-186716, A DUAL METALLOPROTEASE INHIBITOR, IN THE TREATMENT OF HYPERTENSION. BRISTOL-MYERS SQUIBB COMPANY.
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 30 mg PIOGLITAZONE DAILY IN PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM). TAKEDA AMERICA.
A STUDY TO EVALUATE THE EFFECTS OF LANSOPRAZOLE 30 mg QD OR 15 mg QD VERSUS PLACEBO IN PATIENTS WITH NON-ULCER DYSPEPSIA. TAP HOLDINGS INC.
A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF EFFICACY AND SAFETY OF SUSTAINED RELEASE DEXFENFLURAMINE IN OBESE OUTPATIENTS. WYETH AYERST RESEARCH.
EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF CANDESARTAN CILEXETIL IN COMPARISON TO LOSARTAN: A DOUBLE BLIND, MULTICENTER, PARALLEL DESIGN, RANDOMIZED STUDY: THE CANDLE STUDY. ASTRA MERCK, INC.
A 26-WEEK RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF BRL 49653C 4 mg BID WHEN ADMINISTERED TO PATIENTS WITH NIDDM WHO ARE INADEQUATELY CONTROLLED ON A MAINTENANCE DOSE (2.5G/DAY) OF METFORMIN. SMITH-KLINE BEECHAM.
CARING FOR HYPERTENSION ON INITIATION: COSTS AND EFFECTIVENESS (CHOICE PILOT). BRISTOL MYERS SQUIBB.
A COMPARISON OF EFFICACY AND SAFETY OF MIBEFRADIL WITH LOSARTAN IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. ROCHE.
A RANDOMIZED, DOUBLE BLIND, PARALLEL GROUP EVALUATION OF CERIVASTATIN 0.8 mg COMPARED TO CERIVASTATIN 0.4 mg AND PLACEBO PRAVASTATIN 40 mg ONCE DAILY IN PATIENTS WITH HYPERCHOLESTEROLEMIA. BAYER.
A DOUBLE-BLIND COMPARISON OF TWO DOSE REGIMENS OF GATIFLOXACIN AND CIPROFLOXACIN IN THE TREATMENT OF WOMEN WITH ACUTE, UNCOMPLICATED URINARY TRACT INFECTION. BRISTOL-MYERS SQUIBB.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF THE EFFECT OF WEEKLY AZITHROMYCIN ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN SUBJECTS WITH EVIDENCE OF EXPOSURE TO C. PNEUMONIAE. PFIZER.
PLACEBO-CONTROLLED COMPARATIVE TRIAL OF IRBESARTAN 300 mg AND LOSARTAN 100 mg IN SUBJECTS WITH MILD-TO-MODERATE HYPERTENSION. BRISTOL-MYERS SQUIBB.
A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUATING OMERPRAZOLE MAGNESIUM, 10.3 mg and 20.6 mg DAILY, FOR THE TREATMENT OF EPISODIC HEARTBURN. PROCTOR AND GAMBLE.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL 9 WEEK STUDY OF OMAPATRILAT (BMS-186716) IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. BRISTOL-MYERS SQUIBB.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO AND ACTIVE CONTROLLED, PARALLEL DOSE-RANGING STUDY OF THE DUAL METALLOPROTEASE INHIBITOR, BMS-186716, IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. BRISTOL MYERS SQUIBB
A SINGLE-BLIND SAFETY AND EFFICACY STUDY COMPARING A SINGLE DOSE (1200 mg) MICONAZOLE NITRATE VAGINAL OVULE TO MONISTAT 7 VAGINAL CREAM (100 mg MICONAZOLE NITRATE) IN THE TREATMENT OF VULVOVAGINAL CANDIDIASIS (VVC) - PROTOCOL 97-006-P. ADVANCED CARE PRODUCTS.
MULTI-CENTER, PHASE III, PLACEBO CONTROLLED, DOUBLE-BLIND, BLOCK RANDOMIZED, TWO ARMED, FIVE MONTH CROSS-OVER STUDY FOLLOWED BY A ONE YEAR OPEN LABEL PHASE. GRANGEMATIC LTD.
A RANDOMIZED, PLACEBO CONTROLLED, PARALLEL-GROUP STUDY OF CS-866 WITH LONG-TERM SAFETY EVALUATION IN PATIENTS WITH ESSENTIAL HYPERTENSION. SANKYO.
A OPEN-LABEL EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF BRL 49653C WHEN ADMINISTERED AS MONOTHERAPY, TWICE DAILY, TO PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM). SMITH-KLINE BEECHAM.
CLINICAL PROTOCOL FOR A MULTICENTER, DOUBLE-BLIND, PLACEBO CONTROLLED, RANDOMIZED COMPARISON STUDY OF THE EFFICACY AND UPPER GASTROINTESTINAL SAFETY OF 100 mg, 200 mg AND 400 mg SC-58635 BID AND 500 mg NAPROXEN BID IN TREATING THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS. G. D. SEARLE AND COMPANY
CLINICAL PROTOCOL TO EVALUATE THE LONG-TERM SAFETY OF SC-5835 IN TREATING THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS, IND #48,395. G. D. SEARLE AND COMPANY.
CLINICAL PROTOCOL FOR A MULTICENTER, DOUBLE-BLIND, PLACEBO CONTROLLED, RANDOMIZED COMPARISON STUDY OF THE EFFICACY AND UPPER GASTROINTESTINAL SAFETY OF 50 mg, 100 mg AND 200 mg SC-58635 BID AND 500 mg NAPROXEN BID IN TREATING THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS. G. D. SEARLE AND COMPANY.
A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PARALLEL STUDY OF THE EFFECTS OF THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG INDOMETHACIN ON THE ANTIHYPERTENSIVE RESPONSE TO LOSARTAN VERSUS CAPTOPRIL IN PATIENTS WITH ESSENTIAL HYPERTENSION. MERCK.
A RANDOMIZED, DOUBLE-BIND, PLACEBO CONTROLLED SIX MONTH SAFETY AND EFFICACY TRIAL OF 7.5, 15, 30, 45 mg QD OF PIOGLITAZONE IN TYPE II DIABETES MELLITUS PATIENTS (NON-INSULIN DEPENDENT DIABETES MELLITUS, NIDDM). TAKEDA.
A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF OMEPRAZOLE, 10 MG QD AND 20 MG QD, IN PREVENTING HEARTBURN. ASTRA MERCK.
A CLINICAL EVALUATION OF THE EFFECTS OF ESTRADOIL TD AND ETHICOMBI TD, USED SEQUENTIALLY, ON ESTRADOIL-INDUCED ENDOMETRIAL HYPERPLASIA. ETHICAL PHARMACEUTICALS (UK) LTD.
A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED PARALLEL GROUP, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF AN ORAL FORMULATION OF SOY EXTRACT IN THE TREATMENT OF VASOMOTOR SYMPTOMS IN MENOPAUSAL WOMEN. ADVANCED CARE PRODUCTS.
TOPICAL CILODEX (CIPROFLOXACIN 0.3%, DEXAMETHASONE 0.1%) SUSPENSION COMPARED TO CILOXAN (CIPROFLOXACIN 0.3%) SOLUTION AND CORTISPORIN SUSPENSION (NEOMYCIN 0.35%, POLYMYXIN 10,000 IU/ml, HYDROCORTISONE 1.0%) FOR PATIENTS WITH MODERATE TO SEVERE ACUTE OTITIS EXTERNA (AOE). ALCON LABORATORIES, INC.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, SAFETY AND EFFICACY STUDY OF H 199/18 WITH AMOXICILLIN PLUS CLARITHROMYCIN COMPARED TO H 199/18 WITH CLARITHROMYCIN FOR THE ERADICATION OF HELICOBATER PYLORI IN SUBJECTS WITHACTIVE DUODENAL ULCER OR HISTORY OF DUODENAL ULCER DISEASE. ASTRA MERCK.
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FACTORIAL EFFICACY TRIAL OF COMBINATION THERAPY OF METOPROLOL SUCCINATE PLUS FELODIPINE (ONCE DAILY DOSING) IN ADULT PATIENTS WITH HYPERTENSION. SMITHKLINE.
A MULTI-CENTER, DOUBLE-BLIND, PLACEBO CONTROLLED, GROUP-COMPARISON STUDY TO INVESTIGATE THE EFFICACY, TOLERABILITY AND SAFETY OF BAY 12-9566 AS COMPARED TO PLACEBO, IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE OSTEOARTHRITIS OF THE KNEE, OVER 3 YEARS. BAYER.
A FORTY-FIVE DAY, OPEN-LABEL STUDY OF THE SYMPTOMATIC RELIEF EFFECTSOF FLOMAX CAPSULES 0.4 mg DAILY IN PATIENTS WITH THE SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA. BOEHRINGER INGELHEIM.
A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMIZED, PARALLEL GROUP TRIAL TO COMPARE THE EFFICACY AND SAFETY OF THREE DOSES OFMELOXICAM (3.5, 7.5, AND 15, mg) WITH PLACEBO IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE OR HIP; AND WITH DICLOFENAC (100 mg) AS AN ACTIVE CONTROL TO ASSESS TRIAL SENSITIVITY. BOEHRINGER INGELHEIM.
PLACEBO-CONTROLLED STUDY OF HIGHER DOSES OF OMAPATRILAT IN SUBJECTS WITH MILD TO MODERATE HYPERTENSION. BRISTOL MYERS SQUIBB
A PROSPECTIVE RANDOMIZED, OPEN-LABEL BLINDED-ENDPOINT (PROBE) TRIAL COMPARING MICARDIS (TELISARTAN) (80 Mg QD) AND VALSARTAN (80mg QD) IN PATIENTS WITH MILD TO MODERATE HYPERTENSION USING AMBULATORY BLOOD PRESSURE MONITORING. BOEHRINGER INGELHEIM.
A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMIZED, PARALLEL GROUP TRIAL TO COMPARE THE EFFICACY AND SAFETY OF THREE DOSES OF MELOXICAM (7.5, 15, AND 22.5 mg) WITH DICLOFENAC(150 MG) AND PLACEBO IN PATIENTS WITH RHEUMATOID ARTHRITIS. BOEHRINGER INGELHEIM.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 13 WEEK STUDY OF OMAPATRILAT (BMS-186716) IN SUBJECTS WITH ISOLATED SYSTOLIC HYPERTENSION. BRISTOL MYERS SQUIBB.
SAFETY AND EFFICACY OF FIXED COMBINATION METFORMIN / GLYBURIDE PRODUCTS AS FIRST LINE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE INAADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE. BRISTOL MYERS SQUIBB.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, AMLODIPINE, AND PLACEBO CONTROLLED, 10-WEEK STUDY OF OMAPATRILAT IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. BRISTOL MYERS SQUIBB.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ELECTIVE TITRATION STUDY OF OMAPATRILAT IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. BRISTOL MYERS SQUIBB.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, LISINOPRIL AND PLACEBO CONTROLLED TRIAL OF THE ANITHYPERTENSIVE EFFICACY AND SAFETY OF OMAPATRILAT IN BLACK SUBJECTS WITH MILD TO MODERATE HYPERTENSION. BRISTOL MYERS SQUIBB.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 13 WEEK STUDY OF OMAPATRILAT IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION. BRISTOL MYERS SQUIBB.
A LONG-TERM, OPEN-LABEL, MULTI-CENTER TRIAL OF THE SAFETY AND EFFICACY OF NICOSTATIN IN PATIENTS WITH DYSLIPIDEMIA. KOS PHARMACEUTICALS.
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, COMPARATIVE THREE-ARM STUDY, EVALUATION OF THE EFFICACY AND SAFETY OF ORAL HMR 3647 800 mg ONCE A DAY FOR 5 DAYS VS. HMR 3647 800 mg ONCE A DAY FOR 10 DAYS VS. AMOXICILLIN / CLAVULANIC ACID 500/125 mg THREE TIMES A DAY FOR 10 DAYS IN THE TREATMENT OF ACUTE MAXILLARY SINUSITIS IN ADULTS. HOECHST MARION ROUSSEL, INC.
DULOXETINE VERSUS PLACEBO IN THE RELIEF OF STRESS INCONTINENCE. ELI LILLY.
OPEN LABEL SAFETY STUDY OF SUSTAINED-RELEASE (SR) MOXONIDINE IN STAGE 1 AND STAGE 2 HYPERTENSION. ELI LILLY.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FORCED-TITRATION, MULTICENTER TRIAL COMPARING THE SAFETY AND EFFICACY OF ORAL DIOVAN (80/160 mg) ONCE DAILY TO PLACEBO IN ELDERLY SUBJECTS WITH HYPERTENSION. NOVARTIS.
MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL TRIAL TO ACCESS THE EFFECT OF VALSARTAN ON EXERCISE COMPACITY, QUALITY OF LIFE, AND SIGNS AND SYMPTOMS, IN PATIENTS WITH STABLE, CHRONIC CONGESTIVE HEART FAILURE ( NYHA CLASS II _ IV). NOVARTIS.
A RANDOMIZED STUDY OF REPAGLINIDE AND TROGLITAZONE IN TREATMENT OF TYPE 2 DIABETES IN COMBINATION INDIVIDUALLY, USING BOTH THE FIXED DOSE AND A TITRATION TO MAXIMAL EFFECT. NOVO NORDISK
A SINGLE DOSE, PLACEBO-CONTROLLED, MULTICENTER, DOSE RANGING TRIAL OF MT300 IN PATIENTS WITH ACUTE MIGRAINE HEADACHES. POZEN.
A SEVEN-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF PREGABALIN (150 AND 600 mg-DAY) IN PATIENTS WITH CHRONIC LOW BACK PAIN. PARKE DAVIS.
PREGABALIN OPEN-LABEL, EXTENSION SAFETY TRIAL IN PATIENTS WITH CHRONIC PAIN. PARKE DAVIS.
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL STUDY COMPARING THE EFFICACY AND SAFETY OF TRAMADOL HYDROCHLORIDE CONTROLLED RELEASE TABLETS VERSUS ULTRAM VERSUS PLACEBO IN PATIENTS WITH CHRONIC BACK PAIN. PURDUE PHARMA
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL STUDY COMPARING THE EFFICACY AND SAFETY OF TRAMADOL HYDROCHLORIDE CONTROLLED RELEASE TABLETS VERSUS ULTRAM VERSUS PLACEBO IN PATIENTS WITH CHRONIC PAIN DUE TO OSTEOARTHRITIS OF THE KNEE. PURDUE PHARMA
A MULTI-CENTER, OPEN-LABEL STUDY EVALUATING THE SAFETY AND TOLERABILITY OF TRAMADOL HYDROCHLORIDE CONTROLLED-RELEASE TABLETS IN PATIENTS WITH CHRONIC PAIN. PURDUE PHARMA
A SINGLE DOSE, DOUBLE-BLIND, DOSE RANGING, PLACEBO-CONTROLLED SAFETY AND EFFICACY STUDY OF VARIOUS DOSES OF NAPROXEN SODIUM AND METOCLOPRAMIDE IN SUBJECTS WITH ACUTE MIGRAINE HEADACHES. POZEN.
A 52 WEEK, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTICENTER TRIAL TO EVALUATE THE EFFICACY OF ORLISTAT PLUS DIET IN OBESE
HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH ANTIHYPERTENSIVE MEDICATIONS. ROCHE.
A DOUBLE-BLIND RANDOMIZED COMPARISON OF THE EFFICACY AND SAFETY OF 52 WEEKS OF XENICAL THERAPY PLUS DIET IN THE TREATMENT OF OBESITY IN PERI AND POST-MENOPAUSAL WOMEN AT CARDIOVASCULAR RISK. ROCHE.
EVALUATION OF THE SAFETY AND EFFECTIVENESS OF RWJ-10628 IN SUBJECTS WITH CHRONIC PAIN OF BENIGN ORGIN. R.W. JOHNSON.
RANDOMIZED, DOUBLE-BLIND, ACTIVE-AND PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RESPONSE STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFECT ON PAIN AND FUNCTION OF RWJ-57504 IN SUBJECTS WITH OSTEOARTHRITIS OF THE KNEE. R.W. JOHNSON.
CLINICAL PROTOCOL FOR A MULTICENTER, DOUBLE-BLIND, PARALLEL GROUP STUDY COMPARING THE INCIDENCE OF CLINICALLY SIGNIFICANT UPPER GASTROINTESTINAL ADVERSE EVENTS ASSOCIATED WITH SC-58635 400 mg BID TO THAT OF IBUPROFEN 800 mg TID IN PATIENTS WITH OSTEOARTHRITIS OR RHEUMATOID ARTHRITIS, IND #48,395. G.D. SEARLE & COMPANY.
CLINICAL PROTOCOL TO EVALUATE THE LONG-TERM SAFETY OF SC-58635 IN TREATING THE SIGNS AND SYMPTOMS OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS. G.D. SEARLE & COMPANY.
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED COMPARISON STUDY OF THE EFFICACY AND UPPER GI SAFETY OF TWO DOSES OF SC-58635 BID AND NEPROXEN 500 mg BID IN TREATING THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS. G.D. SEARLE & COMPANY.
AN OPEN-LABEL EXTENSION STUDY TO ACCESS THE LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF BRL49653C WHEN ADMINISTERED ONCE OR TWICE DAILY IN COMBINATION WITH METFORMIN TO PATIENTS WITH NON INSULIN DEPENDENT DIABETES MELLITUS (NIDDM). SMITH KLINE.
A 13-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL, MULTICENTER STUDY OF TEVETEN GIVEN IN TITRATED DOSES OF 600 mg OR 1200 mg ONCE DAILY, IN PATIENTS WITH ISOLATED SCHOLASTIC HYPERTENSION (SITSBP>160mmHg AND SITDBP<90mmHg). SMITH KLINE.
LINEZOLID VS. CLARITHROMYCIN FOR THE TREATMENT UNCOMPLICATED SKIN AND SUPERFICIAL SKIN STRUCTURE INFECTIONS. PHARMACIA & UPJOHN.
AN OPEN LABEL, LONG-TERM EXTENSION STUDY OF PIOGLITAZONE (AD-4833) IN TYPE II DIABETES MELLITUS PATIENTS (NON-INSULIN DEPENDENT DIABETES MELLITUS, NIDDM). TAKEDA.
STUDY TO EVALUATE THE EFFECTS OF EM574 5 mg QID, 10 mg TID, 20 mg BID VERSUS PLACEBO IN FEMALES WITH NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE. TAP.
COMPARATIVE SAFETY AND EFFICACY OF CEFDITOREN PIVOXIL AND AUGMENTIN (AMOXICILLIN / CLAVULANATE POTASSIUM) IN THE TREATMENT OF PATIENTS WITH ACUTE MAILLARY SINUSITIS. TAP.
A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED TRIAL OF PLECONARIL IN THE TREATMENT OF PICORNAVIRUS RESPIRATORY TRACT DISEASE (VIRAL SYNDROME CAUSED BY PICORNAVIRUS). VIROPHARMA.
AN OPEN-LABEL, LONG TERM SAFETY EXTENSION STUDY OF SUSTAINED RELEASE DEXFENFLURAMINE IN OBESE OUTPATIENTS. WYETH-AYERST RESEARCH.
AN ECHOCARDIOGRAPHIC FOLLOW-UP STUDY OF SUBJECTS WHO PARTICIPATED IN THE WYETH-AYERST RESEARCH PROTOCOL 0927B1-300-US.
AN ECHOCARDIOGRAPHIC EVALUATION OF PATIENTS EXPOSED TO ANOREXIGENS AS COMPARED TO UNEXPOSED MATCHED CONTROLS. WYETH AYERST RESEARCH.
A RANDOMIZED, PLACEBO CONTROLLED, PARALLEL GROUP, DOUBLE BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MK-0966 12.5 mg VS. NABUMETONE 1000 mg IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE. MERCK.
A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF TWO DOSE LEVELS OF SR90067u, A TRANSDERMAL ESTRODIOL SPRAY IN POST-MENOPAUSAL WOMEN WITH VASOMOTOR SYMPTOMS. SANOFI.
DOUBLE-BLIND, PLACEBO CONTROLLED COMPARISON OF THE EFFICACY AND SAFETY OF PROPIRAM, TRAMADOL (ULTRAM), AND PLACEBO WITH AN OPEN LABEL EXTENSION IN THE TREATMENT OF PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE AND /OR HIP. ROBERTS PHARMACEUTICALS.
A PROSPECTIVE, MULTINATIONAL, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, ACTIVE-CONTROLLED TRIAL IN PATIENTS WITH ESSENTIAL HYPERTENSION TO COMPARE THE EFFECT OF VALSARTAN 80 AND 160 mg, WITH OR WITHOUT THE ADDITION OF HYDROCHLOROTHIAZIDE, ONCE DAILY TO THAT OF AMLODIPINE 5 AND 10 mg ONCE DAILY, WITH OR WITHOUT THE ADDITION OF HYDROCHLOROTHIAZIDE, ON CARDIOVASCULAR MORBIDITY AND MORTALITY. NOVARTIS.
AN OPEN LABEL, LONG-TERM TOLERABILITY STUDY OF PIOGLITAZONE (AD 4833) IN TYPE II DIABETES MELLITUS PATIENTS (NON-INSULIN DEPENDENT DIABETES MELLITUS, NIDDM). TAKEDA.
A TRIPLE-BLIND, RANDOMIZED, PARALLEL, EFFICACY STUDY OF LOSARTAN VERSUS IRBESARTAN IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. MERCK.
A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY COMPARISON OF GLYBURIDE
20 mg/DAY WITH A TITRATED DOSE OF V20001 IN TYPE II DIABETIC PATIENTS. PURDUE PHARMA
A PHASE II DOUBLE BLIND DOSE RESPONSE INVESTIGATION OF THE EFFICACY AND SAFETY OF FOUR DOSES OF SCH58235 COMPARED TO PLACEBO IN SUBJECTS WITH PRIMARY HYPERCHOLESTEROLEMIA. SCHERING-PLOUGH.
A ONE YEAR RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALOSETRON (GR68755) 1 mg BID IN FEMALE SUBJECTS WITH IRRITABLE BOWEL SYNDROME (IBS). GLAXOWELLCOME.
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TWO-YEAR PARALLEL GROUP STUDY OF THE EFFICACY AND SAFETY OF GI198745 0.5MG IN THE TREATMENT AND PREVENTION OF PROGRESSION OF BENIGN PROSTATIC HYPERPLASIA. GLAXO WELLCOME
A COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF CLARITHROMYCIN IMMEDIATE RELEASE TABLETS AND LORACARBEF PULVULES FOR THE TREATMENT OF PATIENTS WITH SECONDARY BACTERIAL INFECTION OF ACUTE BRONCHITIS. ABBOTT LABORATORIES.
A SINGLE-BLIND SAFETY AND EFFICACY STUDY COMPARING A SINGLE DOSE OF MICONZOLE NITRATE 600 MG (12%) VAGINAL CREAM TO MONISTAT 7 VAGINAL CREAM (100 MG MOCONAZOLE NITRATE) IN THE TREATMENT OF VULVOVAGINAL CANDIDIASIS (vvc). ADVANCED CARE PRODUCTS.
A DOUBLE-BLIND, RANDOMIZED, PARALLEL EFFECTIVENESS STUDY OF TWO HYPERTENSIVE TREATMENT REGIMENS; LOSARTEN VERSUS VALSARTAN IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION. MERCK & CO., INC.
A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, MULTIPLE-DOSE STUDY TO COMPARE THE EFFICACY OF FAMOTIDINE/ANTACID COMBINATION, FAMOTIDINE 10MG, ANTACID, AND PLACEBO IN PATIENTS WITH FREQUENT HEARTBURN (NO.2). MERCK & CO., INC.
A STUDY TO EVALUATE THE EFFECT OF LANSPRAZOLE 30MG QD VERSUS OMEPRAZOLE 20MG QD ON RELIEF OF SYMPTOMS IN PATIENTS WITH EROSIVE REFLUX ESOPHAGITIS. TAP.
A SINGLE DOSE, PLACEBO-CONTROLLED, DOSE RANGING TRIAL OF MT 300 IN PATIENTS WITH ACUTE MIGRAINE HEADACHES. POZEN, INC.
PUBLICATIONS:
MAXAQUIN TREATMENT OF CHRONIC BRONCHITIS: EFFICACY IN PATIENTS WHO ARE CIGARETTE SMOKERS. L.I.GILDERMAN, D.O.; M.E. KUSS; M.J. KELLY, M.S. UNIVERSITY CLINICAL RESEARCH ASSOCIATES, INC., 1150 NORTH UNIVERSITY DRIVE, PEMBROKE PINES, FLORIDA 33024.
EFFICACY OF MAZAQUIN IN TREATING CHRONIC BRONCHITIS: STUDIES IN THE ELDERLY vs CEFACLOR. L.I.GILDERMAN, D.O.; M.E.KUSS; M.J.KELLY, M.S. UNIVERSITY CLINICAL RESEARCH ASSOCIATES, INC., 1150 NORTH UNIVERSITY DRIVE, PEMBROKE PINES, FLORIDA 33024.
MAXAQUIN EFFICACY IN TREATMENT OF CHRONIC BRONCHITIS: RESULTS OF STUDIES IN THE ELDERLY POPULATION. L.I.GILDERMAN, D.O.; B.RONIKER, M.D.; M.E.KUSS; M.J.KELLY, M.S. UNIVERSITY CLINICAL RESEARCH ASSOCIATES, INC., 1150 NORTH UNIVERSITY DRIVE, FLORIDA 33024.
MAXAQUIN THERAPY IN THE TREATMENT OF CHRONIC BRONCHITIS: SAFETY AND EFFICACY IN PATIENTS CONCOMITANTLY TREATED WITH THEOPHYLLINE. L.I.GILDERMAN, D.O.; M.E.KUSS; M.J.KELLY, M.S. UNIVERSITY CLINICAL RESEARCH ASSOCIATES, INC., 1150 NORTH UNIVERSITY DRIVE, PEMBROKE PINES, FLORIDA 33024.
EFFICACY OF MAXAQUIN IN TREATING BRONCHITIS: RESULTS OF COMPARATIVE STUDIES vs AMOXICILLIN AND CEFACLOR. L.I.GILDERMAN, D.O.; R.RONIKER, M.D.; M.E.KUSS, UNIVERSITY CLINICAL RESEARCH ASSOCIATES, INC., 1150 NORTH UNIVERSITY DRIVE, PEMBROKE PINES, FLORIDA 33024.
TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION WITH LABELATOL IN THE ELDERLY. THOMAS D. GILES, M.D.; MICHAEL WEBER, M.D.; DAVID W. BARTELS, PHARM D.; HAROLD M. SILBERMAN, N.S.; LAWRENCE I. GILDERMAN, D.O.; JAMES F. BURRIS, M.D.
CEFPROZIL vs CEFUROXIME AXETIL IN MILD TO MODERATE LOWER RESPIRATORY TRACT INFECTION. CEFPROZIL MULTI-CENTER STUDY GROUP. DR. BONNET; DR. GINSBERG; DR. NOLEN; DR. ALWINE; DR. ROSIELLO; DR. PAPPAS; DR. WEISMAN; DR., GILDERMAN; DR. PAUL.
EFFICACY AND TOLERABILITY OF EXTENDED RELEASE FELODIPINE AND EXTENDED-RELEASE NIFEDIPINE IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION. TIMOTHY C. FAGAN, M.D.; BRIAN E. HAGGERT, M.S; CHARLES LISS, M.S.; LARRY I. GILDERMAN, D.O.
QUALITY OF LIFE AND ANTIHYPERTENSIVE THERAPY IN MEN. A COMPARISON OF CATOPRIL WITH ENALAPRIL. M.A. MOORE; J.E. ANGELO; L.I. GILDERMAN, D.O.; ET AL.
BLOOD PRESSURE CONTROL WITH DILTIAZEM XR. A NOVEL EXTENDED RELEASE FORMULATION OF DILTIAZEM HCL IN MATURE AND ELDERLY HYPERTENSIVE
PATIENTS. AMERICAN JOURNAL OF CLINICAL THERAPEUTICS, VOLUME 16., NUMBER 2. PRESENTED AT AMERICAN SOCIATY OF HYPERTENSION - REPRINTED FROM THE NEW ENGLAND JOURNAL OF MEDICINE 328:907-913 (APRIL 1), 1993.
EFFICACY AND SAFETY OF THE NEURAMINIDASE INHIBITOR ZANAMIVIR IN THE TREATMENT OF INFLUENZAVIRUS INFECTIONS. THE NEW ENGLAND JOURNAL OF MEDICINE, SEPTEMBER 25, 1997.